Journal
AMERICAN JOURNAL OF PATHOLOGY
Volume 174, Issue 5, Pages 1735-1744Publisher
ELSEVIER SCIENCE INC
DOI: 10.2353/ajpath.2009.080709
Keywords
-
Categories
Funding
- Japan Applied Enzymology
- Takeda Science Foundation
- Mitsubishi Foundation
- Ministry of Education, Culture, Sports, Science, and Technology of Japan [09670806, 19591205, 19590094]
- The Morinaga Foundation for Health Nutrition
- Osaka Medical Research Foundation for Incurable Diseases
- National Institute of Biomedical Innovation
- Ministry of Health, Labor and Welfare [19A-1]
- Grants-in-Aid for Scientific Research [19591205, 09670806, 19590094] Funding Source: KAKEN
Ask authors/readers for more resources
Duchenne muscular dystrophy is a fatal muscle wasting disease that is characterized by a deficiency in the protein dystrophin. Previously, we reported that the expression of hematopoietic prostaglandin D synthase (HPGDS) appeared in necrotic muscle fibers from patients with either Duchenne muscular dystrophy or polymyositis. HPGDS is responsible for the production of the inflammatory mediator, prostaglandin D-2. in this paper, we validated the hypothesis that HPGDS has a role in the etiology of muscular necrosis. We investigated the expression of HPGDS/prostaglandin D2 signaling using two different mouse models of muscle necrosis, that is, bupivacaine-induced muscle necrosis and the mdx mouse, which has a genetic muscular dystrophy. We treated each mouse model with the HPGDS-specific inhibitor, HQL-79, and measured both necrotic muscle volume and selected cytokine mRNA levels. We confirmed that HPGDS expression was induced in necrotic muscle fibers in both bupivacaine-injected muscle and mdx mice. After administration of HQL-79, necrotic muscle volume was significantly decreased in both mouse models. Additionally, mRNA levels of both CD11b and transforming growth factor beta 1 were significantly lower in HQL-79-treated mdx mice than in vehicle-treated animals. We also demonstrated that HQL-79 suppressed prostaglandin D, production and improved muscle strength in the mdx mouse. Our results show that HPGDS augments inflammation, which is followed by muscle injury. Furthermore, the inhibition of HPGDS ameliorates muscle necrosis even in cases of genetic muscular dystrophy. (Am J Pathol 2009, 174:1735-1744; DOI: 10.2353/ajpath.2009.080709)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available